Hyperbaric oxygen therapy (HBOT) can meaningfully improve hearing in cases of sudden sensorineural hearing loss, but its effectiveness depends heavily on how quickly treatment begins. Patients who started HBOT within about 12 days of losing their hearing recovered roughly four times more hearing than those who waited longer. It works best as an add-on to steroid treatment, not a replacement, and is primarily studied for sudden hearing loss rather than gradual, age-related decline.
How HBOT Works in the Inner Ear
The inner ear is one of the most oxygen-hungry structures in the body, yet it has no direct blood supply of its own. It relies on oxygen diffusing through surrounding fluid called perilymph. When something disrupts that oxygen delivery, the delicate hair cells responsible for hearing can be damaged or destroyed.
HBOT involves breathing pure oxygen inside a pressurized chamber, typically at 2.0 to 2.5 times normal atmospheric pressure. This forces far more oxygen into your blood and tissues than normal breathing can achieve. In the inner ear specifically, it raises the oxygen level in the perilymph, reduces swelling, lowers blood viscosity so it flows more easily through tiny vessels, and dials down the inflammatory response that can worsen damage after the initial injury. The net effect is that starved hair cells get a second chance to recover before the damage becomes permanent.
Recovery Rates and Hearing Gains
In a study of 102 patients who received just one to five HBOT sessions, 44% showed measurable hearing improvement. The results varied by severity: 27% of patients with mild-to-moderate loss improved, 41% with severe loss improved, and 68% of those with profound hearing loss showed gains. That pattern is notable because it suggests HBOT may offer the most benefit to people with the worst initial hearing loss, who also have the most to gain.
The median hearing recovery rate across patients was about 22%, which translates to a partial but clinically noticeable improvement. To put that in practical terms, someone who lost the ability to follow a normal conversation might regain enough hearing to understand speech in a quiet room, though full restoration is not the typical outcome.
Timing Is the Most Important Factor
The single biggest predictor of whether HBOT will help is how soon you start. Patients who began treatment within 12 days of hearing loss onset gained an average of 20.5 decibels and had a recovery rate of about 42%. Those who waited beyond 13 days gained only 3 decibels on average, with a recovery rate of just 9.4%. That is a dramatic difference, and it underscores why sudden hearing loss is treated as a medical urgency.
Research points to roughly 12.5 days as the cutoff where outcomes shift significantly. After that window, the inner ear damage is more likely to have become permanent. Clinical guidelines still consider HBOT a reasonable option up to three months after onset, but the data strongly favors starting as early as possible.
What a Typical Treatment Course Looks Like
A standard course involves 10 to 20 sessions, each lasting about 90 minutes, delivered once daily. You sit or lie inside a pressurized chamber while breathing pure oxygen. The pressure gradually increases at the start and decreases at the end, similar to the sensation of ascending and descending in an airplane.
Clinicians typically reassess after the first 10 sessions. If your hearing has not improved by at least 10 decibels at that point, additional sessions are unlikely to help and treatment is usually stopped. For those who do respond, sessions may continue up to 20 total.
HBOT Versus Steroids Alone
Steroids, given either orally or by injection through the eardrum, remain the first-line treatment for sudden sensorineural hearing loss. HBOT is not positioned as a standalone alternative. Instead, it is most commonly used when steroids alone have not produced sufficient improvement, or alongside steroids from the start in more severe cases.
Major insurance policies reflect this sequencing. Aetna, for example, covers HBOT for sudden hearing loss greater than 30 decibels across three or more consecutive frequencies, but only after a patient has tried both oral and injected steroids without adequate results, and only if HBOT begins within three months of onset. Coverage typically caps at 20 sessions.
Which Types of Hearing Loss Respond
Nearly all the positive evidence for HBOT applies to sudden sensorineural hearing loss, the kind that comes on within hours or days, often in one ear, without an obvious external cause. This is a specific condition affecting roughly 5 to 20 people per 100,000 each year.
There is little evidence that HBOT helps with gradual hearing loss from aging (presbycusis), noise-induced damage that accumulated over years, or hearing loss caused by structural problems in the ear. If your hearing has been declining slowly over months or years, HBOT is unlikely to be recommended or covered by insurance.
Side Effects and Risks
The most common side effect is middle ear barotrauma, essentially pressure-related injury to the eardrum and middle ear space. In one study, barotrauma was observed in 67% of patients after a week of treatment, though most cases were mild. Symptoms include ear pain, a feeling of fullness, and occasionally temporary worsening of hearing. This is the same mechanism that causes ear pain during airplane descent, and it happens because the pressurized chamber puts similar stress on the middle ear.
People who have trouble equalizing ear pressure are at higher risk. This includes anyone with eustachian tube dysfunction, active sinus or upper respiratory infections, or a history of ear surgery. A condition called perilymph fistula, where there is an abnormal opening between the middle and inner ear, can actually be worsened by HBOT because pressurized gas can be forced into the inner ear and trigger vertigo.
The only absolute reason someone cannot receive HBOT is an untreated collapsed lung (pneumothorax). Gas inside the eye from recent surgery is another near-absolute contraindication due to the risk of vision loss. Beyond those, the decision to proceed involves weighing the ear-related risks against the potential hearing benefit, particularly for someone already dealing with sudden hearing loss.
What Realistic Expectations Look Like
HBOT is not a cure for sudden hearing loss. It is a tool that improves the odds of partial recovery, especially when used early and in combination with steroids. Roughly four out of ten patients who start quickly see measurable gains. The improvement is often meaningful enough to affect daily functioning, but complete restoration of hearing to pre-loss levels is uncommon.
If you are considering HBOT, the most actionable takeaway from the research is speed. Every day between onset and treatment reduces the likelihood of benefit. If you experience sudden hearing loss in one ear, getting evaluated within the first few days gives you the widest range of treatment options and the best chance of recovery, whether or not HBOT ends up being part of your plan.